Armenian, Azerbaijani civil society representatives deepen dialogue
Since 8 August, Armenia and Azerbaijan have been making targeted efforts to consolidate progress and deepen dialogue, Armenian National Security Counc...
A highly accurate blood test that uses artificial intelligence to detect multiple cancers from just a few drops of blood is now entering clinical trials across the UK’s National Health Service.
A groundbreaking AI-driven blood test known as miONCO-Dx is set to begin clinical trials with the UK’s National Health Service (NHS), potentially transforming how cancer is detected and diagnosed.
Developed to identify up to 12 of the most common and deadly cancers — including bowel, breast, lung, ovarian, and pancreatic — the test boasts a reported accuracy rate of over 99%, according to Kazinform.
The new trial will involve 8,000 patients and builds on data from more than 20,000 individuals. The UK government has allocated £2.4 million in funding to support the project, which is seen as a potential breakthrough in cancer diagnostics.
Cancer remains a major global health threat, and early detection is critical. In the United States alone, it is the second leading cause of death, with more than 600,000 fatalities annually. Experts emphasize that survival rates can dramatically improve with early diagnosis — nine out of ten bowel cancer patients survive if detected at stage one, compared to just one in ten at stage four.
If successful, the miONCO-Dx test could ease pressure on overburdened healthcare systems by providing a fast, non-invasive, and highly accurate alternative to traditional diagnostic methods.
Russia said on Monday that its troops had advanced in the eastern Ukrainian city of Pokrovsk, a transport and logistics hub that they have been trying to capture for over a year, but Ukraine said its forces were holding on.
At least 37 people have died and five are missing after devastating floods and landslides hit central Vietnam, officials said Monday, as a new typhoon threatens to worsen the disaster.
Russia has launched its new nuclear-powered submarine, the Khabarovsk, at the Sevmash shipyard in Severodvinsk, the Defence Ministry said Saturday.
U.S. President Donald Trump said he does not believe the United States is going to war with Venezuela despite growing tensions, though he suggested President Nicolás Maduro’s time in power may be nearing its end.
On October 21, 2025, an Azerbaijani Airlines (AZAL) Gulfstream G650, call sign 4K-ASG, touched down at Yerevan’s Zvartnots Airport. It was a historic event, commented many.
A prostate cancer blood test has been shown to reduce the risk of dying from the disease by 13% over two decades, researchers say.
Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say.
Russian President Vladimir Putin asked North Korean Foreign Minister Choe Son Hui during talks in the Kremlin on Monday to tell her country's leader Kim Jong Un that everything was "going to plan" in bilateral relations.
U.S. border czar says fentanyl should be considered a WMD.
U.S. states this week warned food aid recipients that their benefits may not be distributed in November if the federal government shutdown stretches into its fourth week.
You can download the AnewZ application from Play Store and the App Store.
            
What is your opinion on this topic?
Leave the first comment